Inhibitory effect of hexapeptide (RGRHGD) on platelet aggregation

Thrombosis Research

Volumn 97, Issue 4, 2000, Pages 191-199

  Wu, Tzong Ming ^a   Li, Ming Liang ^a   Chou, Tz Chong ^b  

^a NATIONAL TAIWAN NORMAL UNIVERSITY   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Molecular modeling analysis; Peptide; Platelet aggregation; RGRHGD; Thromboxane A2

Indexed keywords

ADENOSINE TRIPHOSPHATE; ARACHIDONIC ACID; COLLAGEN; CYCLIC AMP; HEXAPEPTIDE; INTEGRIN; SYNTHETIC PEPTIDE; THROMBIN; THROMBOXANE A2; THROMBOXANE B2;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; HYDROPHILICITY; MOLECULAR MODEL; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RABBIT; THROMBOCYTE AGGREGATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; BUNGAROTOXINS; CALCIUM; CYCLIC AMP; INTEGRINS; OLIGOPEPTIDES; PLATELET AGGREGATION; RABBITS; THROMBOXANE A2; THROMBOXANE B2;

EID: 0033985483     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00149-8     Document Type: Article

References (38)

1. Hynes R.O. Integrins. A family of cell surface receptors Cell. 48:1987;549-554.
2. Ruoslahti E., Pierschbacher M.D. New perspectives in cell adhesion. RGD and integrins Science. 238:1987;491-497.
3. Ginsberg M.H., Loftus J.C., Plow E.F. Cytoadhesions, integrins and platelets. Thrombos Haemostas. 59:1988;1-6.
4. Phillips D.R., Charo I.F., Parise L.V., Fitzgerald L.A. The platelet membrane glycoprotein IIb-IIIa complex. Blood. 71:1988;831-843.
5. Plow E.F., Ginsberg M.H. Cellular adhesion. GPIIb-IIIa as a prototypic adhesion receptor Pro Hemo Throm. 9:1989;117-156.
6. Plow E.F., Pierschbacher M.D., Ruoslahti E., Marguerie G.A., Ginsberg M.H. The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets. Proc Natl Acad Sci USA. 82:1985;8057-8061.
7. Gartner T.K., Bennett J.S. The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets. J Biol Chem. 260:1985;11891-11894.
8. Pytela R., Pierschbacher M.D., Ginsberg M.H., Plow E.F., Ruoslahti E. Platelet membrane glycoprotein IIb/IIIa. Member of a family of Arg-Gly-Asp-specific adhesion receptors Science. 231:1986;1559-1562.
9. Santoro S.A., Lawing W.J. Jr. Competition for related but nonidentical binding sites on the glycoprotein IIb-IIIa complex by peptides derived from platelet adhesive proteins. Cell. 48:1987;867-873.
10. Andrieux A., Hudry-Clergeon G., Ryckewaert J.J., Chapel A., Ginsberg M.H., Plow E.F., Marguerie G. Amino acid sequences in fibrinogen mediating its interaction with its platelet receptor, GPIIbIIIa. J Biol Chem. 264:1989;9258-9265.
11. Lam S.C.T., Plow E.F., Smith M.A., Andrieux A., Ryckwaert J.J., Marguerie G., Ginsberg M.H. Evidence that arginyl-glycyl-aspartate peptides and fibrinogen gamma chain peptides share a common binding site on platelets. J Biol Chem. 262:1987;947-950.
12. Huang T.F., Holt J.C., Lukasiewixa H., Niewiarowski S. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex J Biol Chem. 262:1987;16157-16163.
13. Gan Z.R., Gould R.J., Jacobs J.W., Friedman P.A., Polokoff M.A. Echistatin. A potent platelet aggregation inhibitor from the venom of the viper, Echis carinatus. J Biol Chem. 263:1988;19827-19832.
14. Scarborough R.M., Rose J.W., Hsu M.A., Philips D.R., Fried V.A., Campbell A.M., Nannizzi L., Charo I.F. Barbourin. A GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus m. barbouri. J Biol Chem. 266:1991;9359-9362.
15. Chu C.C., Chu S.T., Chen S.W., Chen Y.H. The non-phospholipase A2 subunit of beta-bungarotoxin plays an important role in the phospholipase A2-independent neurotoxin effect. Characterization of three inotoxins with a common phospholipase A2 subunit Biochem J. 303:1994;171-176.
16. Kwong P.D., Hendrickson W.A., Sigler P.B. β-Bungarotoxin. Preparation and characterization of crystals suitable for structural analysis J Biol Chem. 264:1989;19349-19353.
17. Hopp T.P., Wood K.R. Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci USA. 78:1981;3824-3828.
18. Kyte J., Doolittle R.F. A simple method for displaying the hydropathic character of a protein. J Mol Bio. 157:1982;105-132.
19. Chou T.-C., Hsu L.-Y., Yen M.-H., Ding Y.-A. The inhibitory effect of 2-thienyl 2′ hydroxyphenyl ketone (C85) on platelet thromboxane formation. Thromb Res. 84:1996;83-95.
20. Deluca M., Mcelory W.D. Purification and properties of firely luciferase. Methods Enzymol. 57:1978;3-15.
21. 2+ store. Studies using Fura 2 Biochem Biophys Res Commun. 139:1986;308-314.
22. 1-bungarotoxin from Bungarus multicinctus venom. J Protein Chem. 13:1994;233-236.
23. 1-bungarotoxin from Bungarus multicinctus (Taiwan Banded Krait) venom. J Protein Chem. 12:1993;469-474.
24. Ruggeri Z.M., Houghten R.A., Russell S.R., Zimmerman T.S. Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets. Proc Natl Acad Sci USA. 83:1986;5708-5712.
25. Chiang H.S., Yang R.S., Huang T.F. The Arg-Gly-Asp-containing peptide, rhodostomin, inhibits in vitro cell adhesion to extracellular matrices and platelet aggregation caused by Saos-2 human osteosarcoma cells. Brit J Cancer. 71:1995;265-270.
26. 2 production. Biochem Pharmacol. 31:1982;1158-1160.
27. 2 as an amplifying signal for other agonists Am J Cardiol. 68:1991;11B-15B.
28. Bell R.L., Kennerly D.A., Stanford N., Majerus P.W. Diglyceride lipase. A pathway for arachidonic acid release from human platelets Proc Natl Acad Sci USA. 76:1979;1790-1792.
29. 2 activity specific for phosphatidic acid. A possible mechanism for the production of arachidonic acid in platelets J Biol Chem. 256:1981;5399-5403.
30. Hamberg M., Suensson J., Samuelsson J. Thromboxanes. A new group of biological active compounds derived from prostaglandin endoperoxides Proc Natl Acad Sci USA. 72:1975;2994-2998.
31. Berridge M.J. Inositol triphosphate, diacylglycerol as second messenger. Biochem J. 220:1984;345-360.
32. Nishizuka Y. Turnover of inositol phospholipids and signal transduction. Science. 225:1984;1365-1370.
33. 32P) phosphate. Biochem J. 162:1977;61-73.
34. Kirk C.J., Creba J.A., Downes C.P., Michell R.H. Hormone-stimulated metabolism of inositol lipids and its relationship to hepatic receptor function. Biochem Soc Trans. 9:1981;377-379.
35. Lapetina E.G., Watson S.P., Cuatrecasas P. Myo-inositol 1,4,5-triphosphate stimulates protein phosphorylation in saponin-permeabilized human platelets. Proc Natl Acad Sci USA. 81:1984;7431-7435.
36. Mills D.C.B. The role of cyclic nucleotides in platelets. Kebabian J.W., Nathanson J.A. Cyclic Nucleotides II, Handbook of Experimental pharmacology 58/II. 1982;723-761 Springer-Verlag, Berlin.
37. Kaser-Glanzmann R., Jakabova M., George J.N., Luscher E.F. Further characterization of calcium accumulating vesicles from human blood platelets. Biochim Biophys Acta. 512:1978;1-12.
38. Feinstein M.B., Zavoico G.B., Halenda S.P. Calcium and cyclic AMP. Antagonistic modulators of platelet function Longerecker G.L. The Platelets - Physiology and Pharmacology. 1985;237-269 Academic Press, Orlando, FL.